Related Experiment Video
Updated: Aug 10, 2026

10:03
Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
Published on: August 1, 2017
Bone marrow stromal cell blockade of human leukemic cell differentiation
1Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106-4943.
Blood
|April 15, 1994
Summary
Bone marrow stromal cells can inhibit leukemic cell differentiation, particularly in strongly adherent cells. This inhibition is linked to intercellular communication, suggesting a role for gap junctions in regulating leukemia.
Area of Science:
- Hematology
- Cell Biology
- Cancer Research
Background:
- Bone marrow (BM) stromal cells play a crucial role in regulating hematopoietic cell development.
- Leukemic cell differentiation can be influenced by the bone marrow microenvironment.
- Understanding stromal cell interactions with leukemic cells is vital for leukemia therapy.
Purpose of the Study:
- To investigate the role of bone marrow (BM) stromal cells in inhibiting leukemic cell differentiation.
- To explore the mechanisms underlying stromal cell-mediated regulation of leukemia.
- To determine if leukemic cell adhesion to stromal cells affects differentiation.
Main Methods:
- Coculture of human myeloid leukemic cell lines (HL-60, PLB-985, K562) with BM stromal cells (KM-102).
- Two-color immunofluorescence assay to monitor leukemic cell differentiation (CD14 marker).
- Scanning electron microscopy and intercellular dye transfer to assess cell interaction and communication.
Main Results:
- Strongly adherent HL-60 and PLB-985 cells showed inhibited monocytic differentiation (CD14 expression) upon induction.
- Loosely adherent and nonadherent leukemic cells, and K562 cells, were not inhibited in their differentiation.
- Intimate stromal-leukemic cell interaction and communication correlated with differentiation blockade.
Conclusions:
- Leukemic cell lines exhibit variable adhesion to BM stromal cells, impacting differentiation.
- Stromal cell-mediated inhibition of leukemic cell differentiation is linked to intercellular communication.
- Gap-junction formation is implicated as a significant mechanism in stromal cell regulation of leukemia.
Related Concept Videos
Lineage Commitment
Commitment is the process whereby stem cells:
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

